Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Uterine serous carcinoma: Molecular features, clinical management, and new and future therapies.

Gynecologic oncology - 1 Jan 2021

Lee Elizabeth K, Fader Amanda N, Santin Alessandro D, Liu Joyce F

Abstract excerpt

Uterine serous carcinoma (USC) is an aggressive subtype of endometrial cancer. Multimodality treatment with surgery, radiotherapy, and chemotherapy is commonly used, given its propensity for extrauterine spread, distant recurrences, and poor prognosis. However, the use of molecularly-based therapy is expanding. Here, we review key molecular features of USC, discuss current management, and assess the landscape of...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antibodies, Monoclonal, Humanized
Share to Cystadenocarcinoma, Serous

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Molecular Targeted Therapy

Share to Phenylurea Compounds

Share to Quinolines

Share to Randomized Controlled Trials as Topic

Share to Trastuzumab

Share to Uterine Neoplasms

Source

Identifiers

PMID: 33160694
DOI: 10.1016/j.ygyno.2020.10.017

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 6 Sept 2026. Manifest publication-graph-cohort-2026-09-06.1.

Source receipt: pubmed, retrieved 6 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Uterine serous carcinoma: Molecular features, clinical management, and new and future therapies.PMID 33160694Read ↗

Comprehensive Review of Endometrial Cancer: New Molecular and FIGO Classification and Recent Treatment ChangesSemantic proximity Read ↗

Novel targeted therapies in uterine serous carcinoma, an aggressive variant of endometrial cancer.Semantic proximity Read ↗

Updates in therapy for uterine serous carcinomaSemantic proximity Read ↗

Targeted therapy in uterine serous carcinoma: an aggressive variant of endometrial cancer.Semantic proximity Read ↗

Molecular Classification of Endometrial Carcinomas: Review and Recent UpdatesSemantic proximity Read ↗

Recent Advances in Endometrial CancerSemantic proximity Read ↗

Tailoring Endometrial Cancer Treatment Based on Molecular Pathology: Current Status and Possible Impacts on Systemic and Local Treatment.Semantic proximity Read ↗

Molecular Classification and Emerging Targeted Therapy in Endometrial CancerSemantic proximity Read ↗

Identification of potential therapeutic targets by molecular profiling of 628 cases of uterine serous carcinoma.Semantic proximity Read ↗

New therapeutic targets for endometrial cancer: a glimpse into the preclinical sphere.Semantic proximity Read ↗

Endometrial cancer.Semantic proximity Read ↗

Classification of endometrial carcinoma: more than two types.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.